An apparatus for treating a solid tumour to destroy tumour.
Preferred tumors are esophageal tumor, biliary tract tumor, gastric tumor, pancreatic tumor, malignant melanoma, colorectal tumor, squamous cell carcinoma and cervical tumor.
Preferably, the said tumor is a solid tumor.
The method can also be used for monitoring the effectiveness of the treatment of the vasculopathy, neuroectodermal tumor, epithelial tumor, lymphoid tumor or myelomonocytic tumor.
The present invention provides methods of inhibiting angiogenesis in a malignant tumor, inhibiting metastasis of a malignant tumor and of inhibiting transformation of a benign tumor to a malignant tumor.
The present invention also provides assays for identifying inhibitors of angiogenesis in a malignant tumor, inhibitors of metastasis of a malignant tumor and of inhibitors of transformation of a benign tumor to a malignant tumor.
The drill is advanced from the needle, a hole is drilled into the bone until the drill reaches the tumor, and electrical energy is delivered via the electrically conductive region to destroy the tumor.
Also disclosed is a method of distinguishing a benign tumor from a malignant tumor which overexpresses GLUT-1.
Tumor rejection antigens derived from tumor rejection precursor MAGE-3 have been identified.